Nucleic acid isolation and purification is a process of molecular biology that includes sequencing, polymerase chain reaction, cloning, etc. These procedures have numerous applications in the arena of life science research, genetic engineering, and molecular and forensic diagnostics. The processing of more samples in small time, reduces nucleic acid loss ad degradation and improves laboratory effectiveness and efficiency.
Major Type Segment to Contribute Substantial Demand to the Market
The major type variants in the market include DNA (Viral DNA, Plasmid DNA, Genomic DNA, etc.) and RNA (mRNA, miRNA, Total RNA etc.). Over the years, researchers have succeeded in purifying and separating nucleic moieties such as miRNA, mRNA, genomic DNA and plasmid DNA.
This supports in understanding diseases and their pathologies at a genomic level in detail, which in turn, has proven to be helpful in designing diagnostics and therapeutics for numerous diseases. The disengagement, detachment, purification, and ligation of nucleic acids have become a lot simpler than earlier, thanks to the growing use of RNA/DNA sequencing and technological advancements.
The DNA type segment accounted for the largest share in the market and will continue its dominance over the forthcoming period. The growth of the market is attributed to high demand from research laboratories which will drive the demand in the years to come. The DNA type segment will be followed by RNA segment throughout the forecast period.
Market Insights
The Nucleic Acid Isolation and Purification Market is estimated to grow significantly throughout the forthcoming period thanks to reducing prices of genomic sequencing, companion diagnostics, ongoing development of personalized medicine, and technical developments in methods used for purification and isolation of nucleic acids. Companies are also involved in strategic contracts with global firms to increase their proteomics and genomics businesses.
Leading players operating in the nucleic acid isolation and purification market include Danaher; Qiagen; Roche; Illumina, Inc.; Agilent Technologies; Promega Corporation; and Thermo Fisher Scientific, Inc. These companies have been developing at a fast pace due to significant tie-ups with medical device-, IT-, and healthcare- establishments.
No comments:
Post a Comment